Aeterna Zentaris Inc

Change company Symbol lookup

Select an option...

AEZS Aeterna Zentaris Inc

SPUU.NV Direxion Daily S&P 500 Bull 2X Shares

NEOV NeoVolta Inc

SYBX Synlogic Inc

FIISO Financial Institutions Inc

KA Kineta Inc

TCS Container Store Group Inc

MLGO MicroAlgo Inc

INDI indie Semiconductor Inc

JCI Johnson Controls International PLC

Go

Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). The Company is engaged in the development of its therapeutic asset and has established a pre-clinical development pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinson's disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS). Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-130.